Clinical Trial

the Efficacy and Safety of Oliceridine Fumarate Injection for Acute Pain After Abdominal Surgery

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated August 19, 2025 (before its estimated April 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to learn if Oliceridine fumarate injection works to treat acute pain after abdominal surgery. It will also learn about the safety of Oliceridine fumarate injection. The main questions it aims to answer are: 1. Does Oliceridine fumarate injection works to treat acute pain after abdominal surgery? 2. Does Oliceridine fumarate injection lead to less adverse effect? Researchers will compare Oliceridine fumarate injection to a positive-drug (Sufentanil Citrate) to see if Oliceridine fumarate injection not inferior to sufentanil in the efficacy and safety for acute pain after abdominal surgery. Participants will: 1. Receive patient controlled analgesia treat using Oliceridine or sufentanil after surgery 2. Be followed up every 6 hours until 48 hours after surgery or before discharge
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-07-28.
Trial Details
NCT Number NCT06530563
Lead Sponsor Xiangya Hospital of Central South University
Collaborators: Wu Jieping Medical Foundation
Conditions Acute Pain, Opioid Analgesic Adverse Reaction
Enrollment 606 participants
Start Date 2025-08
Primary Completion 2026-04 (estimated)
Study Completion 2026-05 (estimated)
Updated on ClinicalTrials.gov 2025-08-19